Suspended

Orphans and Vulnerable Children Risk Screening Tool Research Study (Zimbabwe)

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected at a single point in time - Cross-sectional
Who is being recruted

From 2 to 18 Years
+6 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Other

Utilizing specific methods not covered by standard models in order to address unique research questions.
Observational
Study Start: October 2017
See protocol details

Summary

Principal SponsorElizabeth Glaser Pediatric AIDS Foundation
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: October 17, 2017

Actual date on which the first participant was enrolled.

In the first phase of the study, investigators will identify an optimal set of screening questions with acceptable sensitivity and false positive rate, based on the draft 11-question pilot tool. Using the identified questions, investigators will develop a composite screening tool and determine criteria that should be used for identifying children for testing with minimally acceptable sensitivity and false positive rates. In the second phase of the study, investigators will select optimal questions to create a composite screening tool and validate it in a similar study population. Investigators anticipate the accuracy of the tool will be much improved compared to the individual questions. Investigators will also assess the usability of the HIV Risk Screening Tool as measured by the time taken to administer the tool, and perceptions of its ease and simplicity.

Official TitleOrphans and Vulnerable Children Risk Screening Tool Research Study (Zimbabwe)
NCT03343158
Principal SponsorElizabeth Glaser Pediatric AIDS Foundation
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

2260 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Other

Some studies use unique or mixed approaches that don't fit standard categories. These may include innovative observational methods or studies tailored to specific research questions.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 2 to 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

3 inclusion criteria required to participate
Children/adolescents ages 2 up to 18 years living in a household and enrolled in WEI/Zimbabwe and/or partners program;
Children/adolescents ages 2 up to 18 years with HIV status unknown, or who tested negative three or more months ago;
Children/adolescents ages 2 up to 18 years who are healthy or ill (unless they are ill enough to require immediate hospitalization).
3 exclusion criteria prevent from participating
Children/adolescents aged 2 up to 18 years tested HIV positive
Children/adolescents ages 2 up to 18 years who require immediate hospitalization;
Children/adolescents ages 2 up to 18 years who refuse/are refused participation.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

EGPAF Zimbabwe

Harare, ZimbabweOpen EGPAF Zimbabwe in Google Maps
SuspendedOne Study Center